Sho Sato

594 total citations
32 papers, 411 citations indexed

About

Sho Sato is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Sho Sato has authored 32 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Reproductive Medicine and 8 papers in Molecular Biology. Recurrent topics in Sho Sato's work include Ovarian cancer diagnosis and treatment (9 papers), Immune Cell Function and Interaction (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Sho Sato is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Immune Cell Function and Interaction (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Sho Sato collaborates with scholars based in Japan, United States and Germany. Sho Sato's co-authors include Kosei Hasegawa, Keiichi Fujiwara, Hiroyuki Seki, Kazunori Baba, Tomonori Nagai, Takahiro Uotani, Shigetaka Matsunaga, Hiroaki Ishida, Yasushi Takai and Yuji Ikeda and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Sho Sato

27 papers receiving 408 citations

Peers

Countries citing papers authored by Sho Sato

Since Specialization

Citations

This map shows the geographic impact of Sho Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Sato more than expected).

Fields of papers citing papers by Sho Sato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Sato. The network helps show where Sho Sato may publish in the future.

Co-authorship network of co-authors of Sho Sato

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Sato. A scholar is included among the top collaborators of Sho Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Sato. Sho Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profiling 2025 ·Neoplasia ·Sho Sato, Shigehiro Yagishita, Hiroshi Yoshida, Daisuke Shintani, (unknown), Tadaaki Nishikawa, Masanori Yasuda, Keiji Furuuchi, Toshimitsu Uenaka, Akinobu Hamada, Kosei Hasegawa	0
2	Human epidermal growth factor receptor 3 expression in patients with epithelial ovarian cancer: a potential target for ovarian mucinous and clear cell carcinoma 2025 ·International Journal of Clinical Oncology ·Sho Sato, Daisuke Shintani, (unknown), Ryuichi Nakamura, (unknown), Mitsutake Yano, (unknown), Shigehiro Yagishita, Masanori Yasuda, (unknown), Kosei Hasegawa	0
3	Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients 2025 ·International Journal of Clinical Oncology ·(unknown), Masahiro Kagabu, Sho Sato, (unknown), (unknown), (unknown), Tadahiro Shoji, Takashi Hirayama, Yasuhisa Terao, Tsukasa Baba	2
4	Comparative Study of Postmortem MRI and Pathological Findings in Malignant Brain Tumors 2024 ·Cureus ·Norihiko Saito, (unknown), (unknown), Sho Sato, (unknown), Satoshi Fujita, Haruo Nakayama, (unknown), Keisuke Ito, Satoshi Iwabuchi	0
5	Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer 2024 ·Cancers ·Sho Sato, Tadahiro Shoji, Ami Jo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Masahiro Kagabu, Tsukasa Baba	6
6	Co-Clinical Study of [fam-] Trastuzumab Deruxtecan (DS8201a) in Patient-Derived Xenograft Models of Uterine Carcinosarcoma and Its Association with Clinical Efficacy 2023 ·Clinical Cancer Research ·Shigehiro Yagishita, Tadaaki Nishikawa, Hiroshi Yoshida, Daisuke Shintani, Sho Sato, (unknown), (unknown), Masanori Yasuda, Yusuke Ogitani, Takahiro Jikoh, Kan Yonemori, Kosei Hasegawa, Akinobu Hamada	10
7	What can cause cancer patients to attempt suicide? Thiamine deficiency mimicking the symptoms of major depressive disorder 2023 ·Palliative & Supportive Care ·M. Ishida, Sho Sato, Izumi Sato, Akira Yoshioka, (unknown), (unknown), Kosei Hasegawa, Hideki Onishi	1
8	Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer 2022 ·BMC Cancer ·Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Yukari Kobayashi, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi, Kosei Hasegawa	14
9	Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma 2022 ·BMC Cancer ·Masakazu Sato, Sho Sato, Daisuke Shintani, (unknown), (unknown), (unknown), Akira Yabuno, (unknown), Hiroyuki Yoshida, Keiichi Fujiwara, Kosei Hasegawa	5
10	High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo 2020 ·Journal of Gynecologic Oncology ·Yuji Ikeda, Sho Sato, Akira Yabuno, Daisuke Shintani, (unknown), (unknown), Makda Zewde, Takashi Miyamoto, Keiichi Fujiwara, Yusuke Nakamura, Kosei Hasegawa	10
11	Tumor-related mutations in cell-free DNA in pre-operative plasma as a prognostic indicator of recurrence in endometrial cancer 2020 ·International Journal of Gynecological Cancer ·Daisuke Shintani, Taro Hihara, (unknown), Sho Sato, Akira Yabuno, (unknown), Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa	11
12	lncRNA UCA1-Mediated Cdc42 Signaling Promotes Oncolytic Vaccinia Virus Cell-to-Cell Spread in Ovarian Cancer 2019 ·Molecular Therapy — Oncolytics ·(unknown), Hajime Kurosaki, (unknown), (unknown), Tetsuro Oishi, Hiroaki Itamochi, Sho Sato, (unknown), Mai Ito, Kosei Hasegawa, Tasuku Harada, Takafumi Nakamura	30
13	Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing 2019 ·International Journal of Molecular Sciences ·(unknown), Kazuhiro Ikeda, Kuniko Horie‐Inoue, Sho Sato, Atsuo Itakura, Satoru Takeda, Kosei Hasegawa, Satoshi Inoue	20
14	Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer 2017 ·Oncology Reports ·Yuji Ikeda, Kazuma Kiyotani, Poh Yin Yew, Sho Sato, Yuichi Imai, Rui Yamaguchi, Satoru Miyano, Keiichi Fujiwara, Kosei Hasegawa, Yusuke Nakamura	34
15	Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression 2017 ·Oncology Letters ·Sho Sato, Tomomi Kato, Kenji Abe, (unknown), (unknown), (unknown), Masanori Yasuda, (unknown), Keiichi Fujiwara, Kosei Hasegawa	8
16	Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy 2017 ·Molecular Diagnosis & Therapy ·(unknown), Kosei Hasegawa, Tomomi Kato, Sho Sato, (unknown), (unknown), Shoji Nagao, Hiroyuki Seki, Masanori Yasuda, Keiichi Fujiwara	22
17	A case of peritoneal malignant mesothelioma following radiation therapy for cervical cancer 2017 ·Molecular and Clinical Oncology ·Mitsutake Yano, Yuji Ikeda, Tomomi Kato, Mika Sakaki, Sho Sato, Akira Yabuno, Eito Kozawa, Masanori Yasuda	8
18	Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass 2015 ·SpringerPlus ·Tomonori Nagai, Yasushi Takai, (unknown), Hiroaki Ishida, (unknown), Takahiro Uotani, Sho Sato, Shigetaka Matsunaga, Kazunori Baba, Hiroyuki Seki	39
19	Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass 2014 ·SpringerPlus ·Tomonori Nagai, Yasushi Takai, (unknown), Hiroaki Ishida, (unknown), Takahiro Uotani, Sho Sato, Shigetaka Matsunaga, Kazunori Baba, Hiroyuki Seki	57
20	117 Experimental growth retardation in the fetal rat. 1990 ·日本産科婦人科學會雜誌 ·Yumi Nakamura, Tohru Ozaki, Isao Tamura, Sho Sato, Yoshiharu Saito	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact